Impact of Covid-19 on the restless legs syndrome.
Anxiety
Coronavirus
Depression
Exercise
Heart Diseases
Sleep-Related Movement Disorder
Journal
Sleep science (Sao Paulo, Brazil)
ISSN: 1984-0659
Titre abrégé: Sleep Sci
Pays: Germany
ID NLM: 101598477
Informations de publication
Date de publication:
Historique:
entrez:
31
12
2020
pubmed:
1
1
2021
medline:
1
1
2021
Statut:
ppublish
Résumé
The COVID-19 pandemic is strongly impacting global health and mental health, and has caused routine changes in much of the world. All of these changes can have physical and mental consequences for the population. Metabolic changes, mood disorders and their pharmacotherapy, such as the use of antidepressants can increase the chances of developing sleep disorders, such as Restless Legs Syndrome (RLS). As a way to avoid immunosuppression and the greater risk of contamination of COVID-19, it is recommended to perform exercise in light or moderate intensity. This is the first paper to reflect a possible impact of social distancing on RLS, and how it can affect the incidence of mood disorders and metabolic changes in this syndrome, as well as the quality of life of the population. We suggest that regular exercise at light or moderate intensity during home confinement may be effective strategies to minimize the changes caused by the COVID-19 pandemic.
Identifiants
pubmed: 33381285
doi: 10.5935/1984-0063.20200031
pmc: PMC7755267
doi:
Types de publication
Journal Article
Langues
eng
Pagination
186-190Références
Arch Intern Med. 2007 Dec 10;167(22):2453-60
pubmed: 18071167
Brain. 2009 Sep;132(Pt 9):2403-12
pubmed: 19467991
Neuropsychobiology. 2013;68(1):1-14
pubmed: 23774826
Lancet. 2012 Jul 21;380(9838):219-29
pubmed: 22818936
Arch Intern Med. 2005 Jun 13;165(11):1286-92
pubmed: 15956009
Brain Behav Immun. 2020 Aug;88:901-907
pubmed: 32437915
Tremor Other Hyperkinet Mov (N Y). 2019 Jul 19;9:
pubmed: 31413895
Naunyn Schmiedebergs Arch Pharmacol. 1999 Jul;360(1):42-9
pubmed: 10463333
J Cardiovasc Nurs. 2021 Jan/Feb;36(1):23-33
pubmed: 32011348
Neurology. 2016 Dec 13;87(24):2585-2593
pubmed: 27856776
CNS Drugs. 2010 Feb;24(2):89-98
pubmed: 20088617
Prog Cardiovasc Dis. 2020 May - Jun;63(3):386-388
pubmed: 32220590
Rev Esp Cardiol (Engl Ed). 2020 Jul;73(7):527-529
pubmed: 32414660
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Mov Disord. 2008 Jun 15;23(8):1113-21; quiz 1203
pubmed: 18381645
Sleep Med Rev. 2007 Jun;11(3):163-78
pubmed: 17442599
Prim Care Diabetes. 2019 Feb;13(1):87-91
pubmed: 30213520
BMJ. 2020 Mar 26;368:m1198
pubmed: 32217618
J Affect Disord. 2016 Sep 15;202:67-86
pubmed: 27253219
J Neuropsychiatry Clin Neurosci. 2008 Winter;20(1):101-5
pubmed: 18305292
Prog Cardiovasc Dis. 2019 Mar - Apr;62(2):102-107
pubmed: 30802461
Int J Surg. 2020 Apr;76:71-76
pubmed: 32112977
Sleep Sci. 2019 Apr-Jun;12(2):116-121
pubmed: 31879545
Med Sci Sports Exerc. 2009 Jan;41(1):237-42
pubmed: 19092683
J Clin Psychiatry. 2014 Jul;75(7):e679-94
pubmed: 25093484
J Sleep Res. 2020 Aug;29(4):e13052
pubmed: 32246787
Int Heart J. 2019 Sep 27;60(5):1098-1105
pubmed: 31484875
Physiol Res. 2003;52(6):735-41
pubmed: 14640895
Sleep Med. 2020 Apr;68:89-95
pubmed: 32028231
Sleep. 2009 May;32(5):589-97
pubmed: 19480225
Mov Disord. 1995 Sep;10(5):634-42
pubmed: 8552117
JAMA. 2018 Nov 20;320(19):2020-2028
pubmed: 30418471
J Forensic Nurs. 2013 Jan-Mar;9(1):52-64
pubmed: 24158101
Lancet Psychiatry. 2020 Mar;7(3):228-229
pubmed: 32032543
Disabil Rehabil. 2019 Aug;41(17):2006-2014
pubmed: 29561180
Scand J Med Sci Sports. 2015 Dec;25 Suppl 3:1-72
pubmed: 26606383